• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧盟莱姆病风险评估联合行动:莱姆病的临床病例定义

European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis.

作者信息

Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granström M, Guy E, Gray J

机构信息

Hygiene Institute, University of Vienna.

出版信息

Wien Klin Wochenschr. 1996 Dec 13;108(23):741-7.

PMID:8990511
Abstract

The EU Concerted Action on Risk Assessment in Lyme Borreliosis (EUCALB) has consulted other clinicians and scientists in Europe to produce case definitions of the principal manifestations of European Lyme borreliosis. These case definitions will not only be helpful in supporting its own research interests, but are also intended to assist other clinicians in appropriate management and to support further studies aimed at determining the full clinical spectrum of the disease. The case definitions were achieved after a series of meetings organised by EUCALB with other expert clinicians and scientists from twelve European countries. The definitions and the diagnostic criteria presented thus represent the consensus reached at these meetings. The proposed case definitions consider skin, nervous system, cardiac and musculoskeletal presentations and the role of laboratory investigation in supporting diagnosis.

摘要

欧盟莱姆病风险评估联合行动(EUCALB)已咨询欧洲其他临床医生和科学家,以制定欧洲莱姆病主要表现的病例定义。这些病例定义不仅有助于支持其自身的研究兴趣,还旨在帮助其他临床医生进行适当的管理,并支持旨在确定该疾病完整临床谱的进一步研究。这些病例定义是在EUCALB与来自12个欧洲国家的其他专家临床医生和科学家组织的一系列会议之后达成的。因此,所提出的定义和诊断标准代表了这些会议达成的共识。拟议的病例定义考虑了皮肤、神经系统、心脏和肌肉骨骼方面的表现以及实验室检查在辅助诊断中的作用。

相似文献

1
European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis.欧盟莱姆病风险评估联合行动:莱姆病的临床病例定义
Wien Klin Wochenschr. 1996 Dec 13;108(23):741-7.
2
Lyme disease: European perspective.莱姆病:欧洲视角
Infect Dis Clin North Am. 2008 Jun;22(2):327-39, vii. doi: 10.1016/j.idc.2008.01.001.
3
[Lyme borreliosis].[莱姆病]
Ther Umsch. 1998 Jan;55(1):45-51.
4
[Skin manifestations in Lyme borreliosis. 6: Acrodermatitis chronica atrophicans (ACA)].[莱姆病的皮肤表现。6:慢性萎缩性肢端皮炎(ACA)]
Fortschr Med. 1998 Feb 20;116(5):34-6.
5
[Clinical picture of Lyme boreliosis].[莱姆病的临床表现]
Wiad Parazytol. 1999;45(2):143-9.
6
Risk assessment in Lyme borreliosis.莱姆病的风险评估
Wien Klin Wochenschr. 1999 Dec 10;111(22-23):990-3.
7
[Stage-oriented treatment of Lyme borreliosis].[莱姆病的阶段性治疗]
MMW Fortschr Med. 2006 Jun 22;148(25):39-41.
8
[Clinical manifestations and treatment of Lyme disease].[莱姆病的临床表现与治疗]
Klin Mikrobiol Infekc Lek. 2004 Feb;10(1):5-10.
9
[Cutaneous manifestations of Lyme borreliosis].
Ann Dermatol Venereol. 2000 May;127(5):523-7.
10
[Lyme borreliosis in childhood].
Monatsschr Kinderheilkd. 1993 Jun;141(6):513-26.

引用本文的文献

1
Retrospective Analysis of Potential Lyme Disease Clinical Cases in Argentina.阿根廷潜在莱姆病临床病例的回顾性分析。
Microorganisms. 2024 Jul 5;12(7):1374. doi: 10.3390/microorganisms12071374.
2
Prospective incidence epidemiology study protocol: conducting active surveillance to assess the burden of Lyme disease (BOLD) in primary care practices in endemic areas of six European countries.前瞻性发病流行病学研究方案:在六个欧洲国家的地方性流行地区的初级保健实践中开展主动监测,以评估莱姆病(BOLD)的负担。
BMJ Open. 2023 Dec 10;13(12):e070903. doi: 10.1136/bmjopen-2022-070903.
3
The In Vitro Antimicrobial Susceptibility of sensu lato: Shedding Light on the Known Unknowns.
广义的体外抗菌药敏性:揭示已知的未知因素。
Pathogens. 2023 Sep 28;12(10):1204. doi: 10.3390/pathogens12101204.
4
A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019: A Public Health Concern.一项对 2015 年至 2019 年波兰莱姆病发病率的回顾性数据库研究:公共卫生关注点。
Vector Borne Zoonotic Dis. 2023 Apr;23(4):247-255. doi: 10.1089/vbz.2022.0049. Epub 2023 Jan 27.
5
CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.脑脊液 B 淋巴细胞趋化因子(CXCL13)在急性莱姆神经Borreliosis 的早期诊断中的作用。
J Neurol. 2008 May;255(5):782. doi: 10.1007/s00415-008-0974-8. Epub 2008 Mar 17.
6
The NeBoP score - a clinical prediction test for evaluation of children with Lyme Neuroborreliosis in Europe.NeBoP评分——欧洲用于评估莱姆病神经伯氏疏螺旋体病患儿的一种临床预测测试。
BMC Pediatr. 2015 Dec 17;15:214. doi: 10.1186/s12887-015-0537-y.
7
Chronic Lyme disease.慢性莱姆病
Infect Dis Clin North Am. 2015 Jun;29(2):325-40. doi: 10.1016/j.idc.2015.02.006.
8
Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.欧洲持续性莱姆病经验性抗生素研究(PLEASE)——一项针对归因于莱姆病螺旋体病的持续性症状患者进行延长抗生素治疗的随机对照试验的设计
BMC Infect Dis. 2014 Oct 16;14:543. doi: 10.1186/s12879-014-0543-y.
9
Clinical characteristics associated with Borrelia burgdorferi sensu lato skin culture results in patients with erythema migrans.与莱姆病螺旋体狭义皮肤培养结果相关的游走性红斑患者的临床特征。
PLoS One. 2013 Dec 26;8(12):e82132. doi: 10.1371/journal.pone.0082132. eCollection 2013.
10
Chronic or late lyme neuroborreliosis: analysis of evidence compared to chronic or late neurosyphilis.慢性或晚期莱姆病神经伯氏疏螺旋体病:与慢性或晚期神经梅毒相比的证据分析。
Open Neurol J. 2012;6:146-57. doi: 10.2174/1874205X01206010146. Epub 2012 Dec 28.